Overview

The Study of Early Stage Osteonecrosis of Femoral Head With Human Umbilical Cord Mesenchymal Stem Cells

Status:
Suspended
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The purposes of the study is to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells (hUC-MSC) in treating osteonecrosis of femoral head patients.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Sclnow Biotechnology Co., Ltd.